Bolt Biotherapeutics , Inc. (NASDAQ:BOLT), a pharmaceutical company currently trading at $0.33 per share, has announced changes to its corporate bylaws, specifically adjusting the quorum requirements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results